Member of Farmavita.net is offering dossier in European CTD format for Acarbose; 50/100 mg, tablets

Dossier will be available in 3Q 2007.

License for the use of the Dossier is related to initial downpayment and commitment to bulk purchase of blisters.

Acarbose is classified as a medicine for the alimentary tract and metabolism, according to the ATC index.

Offer is valid subject to confirmation, country by country. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. Farmavita.Net is not owner of offered products/licenses and do not take any liability related to them. However, as the licensing agent we do our the best to facilitate that closed licensing agreements are made on mutual benefit of contracting parties and without infringement of intellectual property of third parties.

• SALBU + IPRATROPIUM Inhaler (09/08/2007)
• Fexofenadine Dossier with Supply (10/06/2007)
• 200 Formulation Dossiers (04/03/2007)
• Bisoprilol (06/09/2006)
• Lacidipin (06/09/2006)
• Meloxicam (06/09/2006)
• Ramipril (06/09/2006)
• Triamterene/HCTZ (19/08/2006)
• Triamterene/Epitiazide (19/08/2006)